Turner D P J, Marietou A G, Johnston L, Ho K K L, Rogers A J, Wooldridge K G, Ala'Aldeen D A A
Institute of Infections, Immunity and Inflammation, School of Molecular Medical Sciences, University Hospital, Queen's Medical Centre, Nottingham NG7 2UH, United Kingdom.
Infect Immun. 2006 May;74(5):2957-64. doi: 10.1128/IAI.74.5.2957-2964.2006.
A novel putative autotransporter protein (NMB1998) was identified in the available genomic sequence of meningococcal strain MC58 (ET-5; ST-32). The mspA gene is absent from the genomic sequences of meningococcal strain Z2491 (ET-IV; ST-4) and the gonococcal strain FA1090. An orthologue is present in the meningococcal strain FAM18 (ET-37; ST-11), but the sequence contains a premature stop codon, suggesting that the protein may not be expressed in this strain. MspA is predicted to be a 157-kDa protein with low cysteine content, and it exhibits 36 and 33% identity to the meningococcal autotransporter proteins immunoglobulin A1 (IgA1) protease and App, respectively. Search of the Pfam database predicts the presence of IgA1 protease and autotransporter beta-barrel domains. MspA was cloned, and a recombinant protein of the expected size was expressed and after being affinity purified was used to raise rabbit polyclonal monospecific antiserum. Immunoblot studies showed that ca. 125- and 95-kDa fragments of MspA are secreted in meningococcal strain MC58, which are absent from the isogenic mutant. Secretion of MspA was shown to be modified in an AspA isogenic mutant. A strain survey showed that MspA is expressed by all ST-32 and ST-41/44 (lineage 3) strains, but none of the ST-8 (A4) strains examined. Sera from patients convalescing from meningococcal disease were shown to contain MspA-specific antibodies. In bactericidal assays, anti-MspA serum was shown to kill the homologous strain (MC58) and another ST-32 strain. Escherichia coli-expressing recombinant MspA was shown to adhere to both human bronchial epithelial cells and brain microvascular endothelial cells.
在脑膜炎奈瑟菌菌株MC58(ET-5;ST-32)的现有基因组序列中鉴定出一种新型推定自转运蛋白(NMB1998)。脑膜炎奈瑟菌菌株Z2491(ET-IV;ST-4)和淋病奈瑟菌菌株FA1090的基因组序列中不存在mspA基因。脑膜炎奈瑟菌菌株FAM18(ET-37;ST-11)中存在一个直系同源物,但该序列包含一个提前终止密码子,表明该蛋白可能不在此菌株中表达。预测MspA是一种157 kDa的蛋白,半胱氨酸含量低,与脑膜炎奈瑟菌自转运蛋白免疫球蛋白A1(IgA1)蛋白酶和App分别具有36%和33%的同一性。搜索Pfam数据库预测存在IgA1蛋白酶和自转运β桶结构域。克隆了MspA,表达出预期大小的重组蛋白,经亲和纯化后用于制备兔多克隆单特异性抗血清。免疫印迹研究表明,MspA的约125 kDa和95 kDa片段在脑膜炎奈瑟菌菌株MC58中分泌,而等基因突变体中不存在这些片段。结果表明,MspA的分泌在AspA等基因突变体中发生了改变。菌株调查显示,所有ST-32和ST-41/44(谱系3)菌株均表达MspA,但所检测的ST-8(A4)菌株均不表达。脑膜炎球菌病康复患者的血清中含有MspA特异性抗体。在杀菌试验中,抗MspA血清可杀死同源菌株(MC58)和另一株ST-32菌株。表达重组MspA的大肠杆菌被证明可黏附于人支气管上皮细胞和脑微血管内皮细胞。